HEBA AL-SHOUBAKI: Open Payments
NPI 1548867666 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 14 payments from 7 companies in 2025. Trend: 2023 $1,351 · 2024 $878 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $109 |
| Kestra Medical Technology Services, Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Amgen Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Assure WCD, REPATHA, CAMZYOS, JOT DX, ASSURITY, GALLANT, AMVUTTRA, AVEIR.
Industry payments across CA — which companies pay providers there.
